Gene · 4144
Papers1,624
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,624
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| 8-Cl-Ado and 8-NH2-Ado synergize with venetoclax to target the methionine-MAT2A-SAM axis in acute myeloid leukemia. | Leukemia | 2024 | 38643304 | PubTator, text mining | PubMed |
| S-Adenosyl-l-methionine restores brain mitochondrial membrane fluidity and GSH content improving Niemann-Pick type C disease. | Redox Biol | 2024 | 38599016 | PubTator, text mining | PubMed |
| SUMOylation controls Hu antigen R posttranscriptional activity in liver cancer. | Cell Rep | 2024 | 38507413 | PubTator, text mining | PubMed |
| Development of a Series of Pyrrolopyridone MAT2A Inhibitors. | J Med Chem | 2024 | 38466661 | PubTator, text mining | PubMed |
| Discovery of novel MAT2A inhibitors by an allosteric site-compatible fragment growing approach. | Bioorg Med Chem | 2024 | 38342078 | PubTator, text mining | PubMed |
| Methylthioadenosine Phosphorylase Genomic Loss in Advanced Gastrointestinal Cancers. | Oncologist | 2024 | 38330461 | PubTator, text mining | PubMed |
| METTL16 promotes liver cancer stem cell self-renewal via controlling ribosome biogenesis and mRNA translation. | J Hematol Oncol | 2024 | 38302992 | PubTator, text mining | PubMed |
| Longitudinal plasma proteome profiling reveals the diversity of biomarkers for diagnosis and cetuximab therapy response of colorectal cancer. | Nat Commun | 2024 | 38302471 | PubTator, text mining | PubMed |
| Dynamics of N6-methyladenosine modification during aging and their potential roles in the degeneration of intervertebral disc. | JOR Spine | 2024 | 38283178 | PubTator, text mining | PubMed |
| Tumor- and circulating-free DNA methylation identifies clinically relevant small cell lung cancer subtypes. | Cancer Cell | 2024 | 38278149 | PubTator, text mining | PubMed |
| Prevalence of Genetic Variants and Deep Phenotyping in Patients with Thoracic Aortic Aneurysm and Dissection: A Cross-Sectional Single-Centre Cohort Study. | J Clin Med | 2024 | 38256594 | PubTator, text mining | PubMed |
| Temporal Quantitative Proteomic and Phosphoproteomic Profiling of SH-SY5Y and IMR-32 Neuroblastoma Cells during All-Trans-Retinoic Acid-Induced Neuronal Differentiation. | Int J Mol Sci | 2024 | 38256121 | PubTator, text mining | PubMed |
| Protein interaction networks in the vasculature prioritize genes and pathways underlying coronary artery disease. | Commun Biol | 2024 | 38216744 | PubTator, text mining | PubMed |
| Hereditary Thoracic Aortic Diseases. | Diagnostics (Basel) | 2024 | 38201421 | PubTator, text mining | PubMed |
| Doa10/MARCH6 architecture interconnects E3 ligase activity with lipid-binding transmembrane channel to regulate SQLE. | Nat Commun | 2024 | 38195637 | PubTator, text mining | PubMed |
| Blocking methionine catabolism induces senescence and confers vulnerability to GSK3 inhibition in liver cancer. | Nat Cancer | 2024 | 38168934 | PubTator, text mining | PubMed |
| Identification of a Sonically Activated Degrader of Methionine Adenosyltransferase 2A by an in Silico Approach Assisted with the Hole-Electron Analysis. | J Med Chem | 2024 | 38166392 | PubTator, text mining | PubMed |
| Cysteine and homocysteine can be exploited by GPX4 in ferroptosis inhibition independent of GSH synthesis. | Redox Biol | 2024 | 38150992 | PubTator, text mining | PubMed |
| MAT2A inhibition suppresses inflammation in Porphyromonas gingivalis-infected human gingival fibroblasts. | J Oral Microbiol | 2024 | 38130504 | PubTator, text mining | PubMed |
| Combined inhibition of MTAP and MAT2a mimics synthetic lethality in tumor models via PRMT5 inhibition. | J Biol Chem | 2024 | 38000655 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4144/papers?page=7